|
|
|
Taglich's Company Profile
for: |
|
|
|
Most Recent Update |
|
Updated
Research Report (Dated October 9, 2008) |
|
What's New |
|
New information will be posted soon... |
|
Company Description |
|
Headquartered in San Clemente, California, Micro Imaging Technology, Inc. is a development stage Company whose operations are conducted through its majority (81%) owned subsidiary, Micro Imaging Technology (MIT). MIT is focused on developing and marketing rapid systems and processes that detect and identify microbial organisms. |
|
Taglich Research Reports |
Updated
Earnings Note (Dated September 16, 2008)
Initial
Research Report (Dated August 18, 2008)
All Research Reports are in Adobe Acrobat format.
(for the latest Adobe Acrobat reader click
here)
*
The information and statistical data contained
herein have been obtained from sources, which we believe to be
reliable but in no way are warranted by us as to accuracy or
completeness. We do not undertake to advise you as to changes in
figures or our views. This is not a solicitation of any order to
buy or sell. Taglich Brothers, Inc. is fully disclosed with its
clearing firm, Pershing, LLC, is not a market maker and does not
sell to or buy from customers on a principal basis. The above
statements are the opinion of Taglich Brothers, Inc. and are not
a guarantee that the target price for the stock will be met or
that predicted business results for the company will occur.
There may be instances when fundamental, technical and
quantitative opinions contained in the reports are not in
concert. We, our affiliates, any officer, director or
stockholder or any member of their families may from time to
time purchase or sell any of the above-mentioned or related
securities. Analysts and members of the Research Department are
prohibited from buying or selling securities issued by the
companies that Taglich Brothers, Inc. has a research
relationship with, except if ownership of such securities was
prior to the start of such relationship, then an Analyst or
member of the Research Department may sell such securities after
obtaining expressed written permission from the Director of
Research. All research issued by Taglich Brothers, Inc. is based
on public information. Taglich Brothers, Inc. does not currently
have an Investment Banking relationship with the company
mentioned and was not a manager or co-manager of any offering
for the company within the last three years. The company paid
for the creation and dissemination of research reports an
engagement fee of $6,000 (USD) on June 2008, and after
publication of the initial report will pay a monthly monetary
fee of $2,000 (USD) to Taglich Brothers, Inc. for the creation
and dissemination of research reports. For further information
and Taglich Brothers, Inc. ownership data please refer to each
individual report. |
|
Send this Page to a friend |
|
To send this page to a friend, just fill out the form below and press
the "send it" button!
|
|
|
Taglich Covered Companies |
AeroCentury Corp.
Anglo Swiss Resources, Inc.
BioForce Nanosci. Holdings, Inc.
Carbiz, Inc.
Cardium Therapeutics, Inc.
Command Security Corp.
CTI Industries Corp
Derma Sciences, Inc.
DRI Corporation
EnerLume Energy Mgt. Corp.
GammaCan International, Inc.
Hartmarx Corporation
Hyperdynamics Corporation
INX, Inc.
Life Partners Holdings, Inc.
Lifeway Foods, Inc.
Littlefield Corporation
Micro Imaging Tech, Inc.
NeoGenomics, Inc.
Orchids Paper Products
Park City Group, Inc.
Pressure BioSciences, Inc.
Radiant Logistics, Inc.
Reed's Inc.
Salon Media Group, Inc.
Simulations Plus, Inc.
SMF Energy Corporation
TranSwitch Corporation
UFP Technologies, Inc.
US 1 Industries, Inc.
Wave Systems Corp.
Williams Controls, Inc.
|
|
